MannKind Corp (NASDAQ:MNKD)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.

Results 1 - 20 of 163 : 1 2 3 4 5 6 7 8 9 Next »

Recs

0
Member Avatar longverylong (< 20) Submitted: 7/11/2014 7:41:34 PM : Outperform Start Price: $10.11 MNKD Score: -3.66

ADCOM - +ve
Approval - YESSSS
BUyout - Maybe
Partnership - Maybe
Before July 18... Hope so :)

Recs

0
Member Avatar ArdyAr (93.93) Submitted: 6/30/2014 3:12:18 PM : Outperform Start Price: $11.03 MNKD Score: -12.66

Saves the diabetic from injections.

Recs

0
Member Avatar Topdoginvesting1 (< 20) Submitted: 6/30/2014 10:34:19 AM : Outperform Start Price: $11.00 MNKD Score: -12.34

Partnership or Buyout, no doubter..

Recs

1
Member Avatar BiotechWilson (38.58) Submitted: 6/18/2014 10:25:50 AM : Underperform Start Price: $10.52 MNKD Score: +8.80

MannKind is incredibly expensive for what it is (and what it can earn), and I think the bulls are overconfident in Afrezza's ability to grow its share of the insulin market. It is also concerning that MannKind cannot secure a commercialization deal with anyone.

Recs

1
Member Avatar Investinguppy (< 20) Submitted: 6/17/2014 11:01:54 PM : Outperform Start Price: $10.59 MNKD Score: -9.47

Inhalable insulin might become a game changer. The technosphere technology might also be useful for a number of different drugs, and the CEO Al Mann has experience bringing medical devices to market (previously insulin pumps).

My largest holding.

Recs

0
Member Avatar FNN31 (30.77) Submitted: 6/12/2014 3:44:14 AM : Underperform Start Price: $10.38 MNKD Score: +7.70

Even if they get FDA approval, there is commercialization hurdle, and then the market pentration hurdle. Efficacy will be first concern and then safety.

Recs

0
Member Avatar jastep1 (< 20) Submitted: 6/3/2014 7:57:43 PM : Outperform Start Price: $9.71 MNKD Score: -2.36

This company has jumped through all the hoops thrown in front if it by the FDA. Inhaled insulin represents a new treatment which allows the administration of insulin without a needle, and works well according to several testimonials so far. Given the increasing number of diabetics it will likely soar.

Recs

0
Member Avatar cofcgrad (< 20) Submitted: 5/31/2014 12:39:52 AM : Outperform Start Price: $9.05 MNKD Score: +5.23

Game changing product in an ever increasing user base.

Recs

0
Member Avatar byonts (< 20) Submitted: 4/23/2014 12:32:05 PM : Outperform Start Price: $6.39 MNKD Score: +47.31

Developed an inhalant insulin for both type 1 and type 2 diabetis. It is not yet approved, but this is major break in diabetis treatment.

Recs

0
Member Avatar DrGarnicus (39.48) Submitted: 4/10/2014 3:37:47 PM : Outperform Start Price: $6.90 MNKD Score: +33.68

July 15th

Recs

0
Member Avatar Piggybank99 (64.05) Submitted: 4/4/2014 6:48:14 PM : Outperform Start Price: $6.12 MNKD Score: +53.02

This company recently got its inhalable insulin approved by the FDA, and once it gets on the market, prices will go through the roof.

Recs

0
Member Avatar kickbishopbrenna (32.53) Submitted: 4/4/2014 10:42:57 AM : Outperform Start Price: $6.87 MNKD Score: +37.42

no insulin injections..wow, its a "pot-shot" but with FDA approval discussions due to start, its worth a punt, especially as the select committee have recommended it.

Recs

0
Member Avatar seti03 (< 20) Submitted: 3/28/2014 4:22:43 PM : Outperform Start Price: $4.44 MNKD Score: +113.86


hmmm, works quicker and no more sticking yourself like a pin cushion. What's not to approve???

Recs

2
Member Avatar usubanas (99.39) Submitted: 3/28/2014 1:55:16 PM : Underperform Start Price: $5.02 MNKD Score: -87.86

predict FDA panel will vote negatively next week.

Recs

1
Member Avatar MOEHESTON (< 20) Submitted: 3/22/2014 9:41:19 AM : Outperform Start Price: $5.90 MNKD Score: +59.50

Unless all are not being told something. All elements have been answered. The ADCOM article (yet to surface) will probably not paint a favorable picture creating one more dip. Then FDA response (April 15th).

Recs

2
Member Avatar palm91 (34.40) Submitted: 3/3/2014 2:42:13 PM : Outperform Start Price: $6.08 MNKD Score: +53.64

best bet in biomeds, look for 25billion MC

Recs

0
Member Avatar jdowning22 (< 20) Submitted: 1/18/2014 8:06:56 PM : Outperform Start Price: $5.56 MNKD Score: +67.57

New drug coming soon... Hopefully

Recs

0
Member Avatar dswallen (48.67) Submitted: 1/15/2014 5:44:35 PM : Outperform Start Price: $6.00 MNKD Score: +55.28

Thinking the drug gets approved and we get a big pop. After that, time to sell sell sell.

Recs

0
Member Avatar babatariq (< 20) Submitted: 1/10/2014 12:29:17 AM : Outperform Start Price: $6.69 MNKD Score: +38.29

novel treatment for dibetes,in multibillion industry.

Recs

1
Member Avatar optionsmaster (59.19) Submitted: 12/20/2013 10:50:00 AM : Outperform Start Price: $4.98 MNKD Score: +86.96

New product launch of diabetes drug

Featured Broker Partners


Advertisement